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Staphylococcal leucotoxins result from the association of class S components and class F component inducing the activation and
the permeabilization of the target cells. Like α-toxin, the leucotoxins are pore-forming toxins with more than 70% β-sheet. This
was conﬁrmed by attenuated total reﬂectance Fourier transform infrared (ATR-FTIR) spectroscopy. In addition, threonine 28 of
a predicted and conserved β-sheet at the N-terminal extremity of class S proteins composing leucotoxins aligns with histidine 35
of α-toxin, which has a key role in oligomerization of the ﬁnal pore. Flow cytometry was used to study diﬀerent aminoacid substi-
tutions of the threonine 28 in order to evaluate its role in the biological activity of these class S proteins. Finally, results show that
threonine 28 of the leucotoxin probably plays a role similar to that of histidine 35 of α-toxin. Mutations on this threonin largely
inﬂuenced the secondary interaction of the class F component and led to inactive toxin.
Copyright © 2006 L. Baba Moussa et al. This is an open access article distributed under the Creative Commons Attribution
License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly
cited.
INTRODUCTION
Staphylococcus aureus (S aureus) is one of the most fre-
quently isolated bacterium in hospital routine, fearing in-
fections that may aﬀect any organs and tissues. Having de-
veloped resistance to most of antimicrobials, it is now re-
sponsible for 5–15% of nosocomial infections, depending
on hospital sites and services [1]. The pathogenicity of this
bacterium is caused by a series of adhesion factors [2]a n d
toxins. Among these toxins, staphylococcal leucotoxins are
a family of bicomponents toxins [3] that result from the
association of class S and class F components that interact
sequentially and synergistically [4], inducing the activation
and the permeabilization of the target cells. The class S pro-
tein ﬁrst binds to the membrane of target cells and then
allows the secondary binding of class F component. These
toxins target polymorphonuclear cells (PMNs), monocytes,
macrophages, and erythrocytes [5, 6]. Among this family of
toxins, Panton-Valentine leucocidin (LukS-PV + LukF-PV)
and gamma-hemolysin, which generates two toxins (HlgA +
HlgBandHlgC+HlgB),activateresponseofspeciﬁccellsvia
aC a 2+ inﬂux and form lethal transmembrane pores. LukS-
PV, HlgA, and HlgC are class S components, while LukF-
PV and HlgB are class F components (Figure 1). The genes
encoding these toxins have been cloned and sequenced [7–
10]. Sequence homologies are very important inside the two
classesofproteins.Identitiesareupto55–70%forclassSand
70–80% for class F proteins, but only 18–25% between the
twoclasses[11,12].Additionalhomologiesexistbetweenthe
two classes of proteins and other pore-forming toxins such
as with staphylococcal α-toxin [13]. Like α-toxin of Sa u -
reus, leucotoxins are pore-forming toxins with predominant
β-sheet [13]. By aligning leucotoxins and α-toxin (Figure 2),
Thr28 appears preserved into a predicted β-sheet at the
N-terminal extremity of the leucotoxins and corresponds
to His35 of α-toxin [14]. His35 has a role in the protein
oligomerization and plays a critical role in its function [15].
The aim of this work was to study the functional tolerance2 Journal of Biomedicine and Biotechnology
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Figure 2: Partial alignment α-toxin sequence and class S compo-
nent sequence of the leucotoxins.
by leucotoxins of diﬀerent substitutions of threonine 28 of a
class S protein. Some of the mutations were predicted to dis-
ruptthesecondβ-sheetattheN-terminalextremity.Thesec-
ondary structure alteration of the puriﬁed mutated proteins
was conﬁrmed by Fourier transform infrared spectroscopy,
and their biologicals activities were evaluated by ﬂow cy-
tometry onto human circulating PMNs and rabbit erythro-
cytes.
MATERIALS AND METHODS
Cloningandsequencingofthemutatedproteins
DNA fragments corresponding to secreted proteins and con-
taining the putative 3  inverted repeats were ampliﬁed via
dedicated oligonucleotides containing EcoR1 restriction se-
quences at their 5 -end. After a further EcoR1r e s t r i c t i o n ,
the ampliﬁed DNA fragments were cloned in the EcoR1-
dephosphorylated pGEX-6P-1 (Amersham Biosciences, Or-
say, France) expression vector. The correctly oriented re-
combinant plasmids were used as templates for any of the
mutations discussed in this work. Site-directed mutagene-
sis was achieved by using the Quick Change Mutagenesis kit
(Stratagene,Amsterdam,TheNetherlands).Brieﬂy,reactions
were performed in the presence of 5ng of template (5.8kb),
0.25mM dNTP, 0.4nM of each dedicated oligonucleotide,
a n d5Uo fP f uT u r b oD N Ap o l y m e r a s ei n5 0μL. Temper-
atures of hybridization, elongation, and denaturation were
50◦C, 68◦C, and 95◦C during 30 seconds, 3 minutes, 30 sec-
onds, and 1 minute, respectively. Initial templates were elim-
inated with an 80 minutes DpnI restriction, and 2.5μLo f
the resulting mixture was used for transformation of 80μL
of XL1 Blue Ec o l iXL1 Supercompetent Blue cells [recA1
endA1 gyrA96 thi1 hsdR17 supE44 relA1 lac (F  proAB lacIq
ZΔM15 Tn10 (tetr))]. Mutated genes were sequenced from
Plasmid Midi kit preparations Qiagen (Paris, France), and
plasmids only containing the mutation were electroporated
at 1.8kV, 200Ohms, 25μFd in 80μlo fEco l iBL21 [F-, ompT,
hsdS( rB−, mB−), gal (52, 53)] (Amersham Biosciences, Or-
say, France) previously stored at −80◦Ca t2 . 0A 600nm units
in 0.1mM Hepes, pH 7.0. Electroporated cells were re-
generated in SOC medium (1%(w/v) tryptone, 0.5%(w/v)
yeast extract, 10mM NaCl, 10mM MgCl2,1 0m MM g S O 4,L. Baba Moussa et al 3
20mM glucose, pH 7.0) for 1 hour at 37◦C. Transformed
bacteria were ﬁnally treated and plated as recommended
(GST Gene Fusion System (Amersham Biosciences, Orsay,
France)).
PURIFICATION OF EC OLIRECOMBINANT
LEUCOTOXINCOMPONENTS
The mutated proteins were puriﬁed as glutathione-S-
transferase-(GST) fusioned leucotoxins. Recombinant Ec o l i
BL 21 mutated clones were inoculated from a starter culture
into 2×400mL of TY medium ﬁlled in two-liter Erlenmeyer
ﬂasks, and cultivated for 6 hours before overnight induc-
tion of the GST-fusioned protein with 0.2mM IPTG. Bac-
teria were harvested by centrifugation and concentrated to
30%(w/v) into 30mM NaH2PO4, 150mM NaCl, and 1mM
EDTA,pH7.0.Then,bacteriaweredisruptedat9000psiwith
a French pressure press (SLM Instruments, Ill, USA; Bior-
itech, Joinville, Juine, France). Cell debris were discarded by
a 30-minute centrifugation at 30000×g at 6◦C, and GST ac-
tivitywasmeasuredat340nmasrecommended.Avolumeof
lysate equivalent to 4mg of titrated GST was applied onto a
Glutathione Sepharose 4B (Pharmacia) column equilibrated
with 60mM Tris-HCl, pH 8.0. The fusion protein was eluted
in the same buﬀer containing 30mM glutathion, and ma-
terials were further digested overnight by 5U of PreScis-
sion protease (Pharmacia) per mg of eluted proteins. The
leucotoxin components were puriﬁed through a 1.35M to
0.45M (NH4)2SO4 gradient applied on an alkylsuperose fast
performance liquid chromatography (Pharmacia). The pro-
teins were eluted at 0.75M (NH4)2SO4. The pre-puriﬁed
F components were dialyzed against 30mM MES, pH 6.3,
and puriﬁed to homogeneity by a MonoS FPLC through a
0 to 150mM NaCl gradient, with elution around 90mM
NaCl. Puriﬁed proteins were controlled by SDS-PAGE and
radial gel immunoprecipitation and stored at A280nm=1.0a t
−80◦C.
Preparationofhumanpolymorphonuclearcells
Twelve milliliters of J-Prep solution (TechGen, Les Ulis,
France) were added to 30mL of buﬀy coats from healthy
donors diluted with 10mL of 0.9%(w/v) NaCl, and cen-
t r i f u g e df o r2 0m i n u t e sa t8 0 0× g at room temperature.
The cell pellet was suspended in 40mL of 0.9%(w/v) NaCl,
1.5%(w/v) dextran and left to sedimentation for 30 min-
utes. The supernatant was carefully removed and then cen-
trifuged at room temperature at 800 ×g for 10 minutes. The
new supernatant was discarded and the erythrocytes pellet
containing PMNs was resuspended and lysed into 18mL of
apyrogenic water for 45 seconds, before complementing the
suspension with 2mL of 9%(w/v) NaCl. After two washing
steps in 50mL of 140mM NaCl, 5mM KCl, 10mM glucose,
0.1mMethyleneglycol-bis(beta-aminoethylether)N,N,N ,
N -tetraacetic acid, 10mM Hepes, and 3mM Tris Base (pH
7.3),thecellsweresuspendedandadjustedto2×106 cells/mL
in the same buﬀer. The latter buﬀer was used to wash the
cells treated with the Ca2+-speciﬁc ﬂuorescent probe Fluo-4
(Molecular Probes, Eugene, Oregon, USA).
Labelledproteins
LukS-PV G10C, a functional cystein mutated protein [16],
was labelled with ﬂuorescein 5-maleimide (Molecular
Probes, Lerden, The Netherlands) at a 5-fold excess for a
10μM protein solution for 30 minutes at room tempera-
ture in 50mM Na2HPO4,0 . 1 5 MN a C l ,1 m ME D T A ,a n d
Na2, pH 7.0. The coupling reaction was stopped by the ad-
dition of 10mM β-mercaptoethanol. The mixture was then
desalted, and the coupling yield was determined by the ratio
of the determined concentration of ﬂuorescein (ε490nm =
81,900cm−1· mol−1) and that of the protein determined by
the Bradford’s titration (Biorad, Ivry, Seine, France).
Flowcytometrymeasurements
E xpe rime ntsw e r emad ewith5×105 cells/mLloadedin5μM
Fluo-4 solutions during 1 hour at 37◦C, then washed and re-
suspended in the presence of 1.1mM Ca2+ for the evaluation
oftheCa2+ entry.Eachcomponentconstitutingtheleucotox-
ins was generally added at 1nM. Flow cytometry measure-
ments were performed by using a FacSort cytometer (Becton
Dickinson,LePontdeClaix,France)equippedwitha15mW
argon laser tuned at 488nm. Forward (FSC) and side (SSC)
light scatter dot plots acquired from 3000 puriﬁed leucocytes
were classically gated [14, 17]. Fluo-4 ﬂuorescence due to the
calciumpenetrationwasrecordedfromtheﬂuorescencelight
1( F L 1 :λEm = 530nm) every 30 seconds during 45 minutes.
After basic ﬂuorescence subtraction, results were compared
to the maximum ﬂuorescence obtained with controls which
indicated the potentiality of the diﬀerent pairs of leucotox-
ins for the opening of Ca2+ channels. The ﬂuorescence light
3( F L 3 :λEm = 650nm) was used to record the ﬂuorescence
of ethidium applied at 25nM together with the leucotoxins.
This ﬂuorescence increased when the molecule entered the
cells by the pores formed through the plasma membrane and
combined with nucleic acids. Means from four series of sig-
niﬁcant data, at least, obtained from PMNs of four or more
diﬀerent donors were calculated by Lysis 2TM software (Bec-
ton Dickinson), and the results were expressed as regression
curves by using SigmaPlot facilities as mean percentages of
maximum ﬂuorescence detected from controls. Standard de-
viations were not shown for clarity of the ﬁgures, but did
not vary more than ±6% as determined by SigmaPlot 8.0 re-
source.
By using a full functional ﬂuorescein-labelled LukS-PV
G10C, the binding abilities of LukS-PV and inactive mutants
combined with 3nM LukF-PV were determined by competi-
tion experiments in the absence of extracellular calcium, us-
ing a ﬁxed concentration of 20nM of the labelled LukS-PV
G10C and variable concentrations of 1, 5, 10, 20, 50, 100,
and 200nM of the mutated proteins. The residual ﬂuores-
cence at the cell surface was gated during 50 minutes after
the application of the protein couples X + LukF-PV, in order4 Journal of Biomedicine and Biotechnology
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Figure 3: Philogenetic tree of peptidic homologies between the leucotoxins and α-toxin of S aureus. Unit = Euclidian distance (DNA Star,
Ltd, London).
to minimize the inﬂuence of lysed cells in the data. Apparent
inhibition constants (kiapp) were deduced from projection to
abscise the 50% means ﬂuorescence values (IC50), with the
following equation:
kiapp = IC50/1+[F]/KdF,( 1 )
where [F] is the concentration of the ﬂuorescent LukF-PV
LukS-PV Gly10Cys and KdF = 3nM[18].
SecondarystructuredeterminationbyATR-FTIR
ATR-FTIR spectra were recorded on Biorad FTS 185 FTIR
spectrometer equipped with DTGS detector with CSL win-
dow, a KBr beamspliter, and an ATR attachment by Specac.
Typically 32 interferograms were collected, Fourier trans-
formed to a nominal resolution of 0.5cm−1,a n da v e r a g e d .
The instrument was constantly purged with dry air. Spectra
were corrected by a subtracted background obtained with an
ATR crystal and no sample. The residual absorbance of H20
was subtracted to give an almost ﬂat baseline between 1880
and 1720cm−1. Before analysis, the leukotoxins were exten-
sively dialyzed against 10mM Hepes (pH 7.0). For the exper-
iments, 28 to 40μg of each protein contained in 40μL of the
given leukotoxin solution were deposited and dried in thin
layer on one side of a 10 reﬂections Ge crystal (45◦Cc u t ) :
the crystal was housed in liquid cell and ﬂushed with D2O-
saturated nitrogen for 45 minutes before collecting the re-
ported spectra.
The ATR-FTIR spectra were processed using the Bio-
rad Win-IR software. Spectra were dissolved to 2cm−1,
and the amide I  band, between 1600 and 1700cm−1,w a s
curve-ﬁtted with a sum of Lorentzians, using nonlinear least
squares ﬁtting of Levenberg-Marquadt method. No parame-
terwasconstrained.Therelativecontentsofsecondarystruc-
ture elements were estimated by dividing the area of in-
dividual peak, assigned to particular secondary structures,
according to Byler and Susi [19], by the area of the whole
amide I  band; the components around 1600cm−1, resulting
from the side chains, were excluded.
RESULTS
Secondarystructureprediction
The secondary structure prediction for class S and class
F proteins reveals signiﬁcant homologies, as expected for
proteins harbouring from 60 to 98% of sequence identity
[20]. The sequence alignment by the software DNAStar of
α-toxins and two component leucotoxins of class S shows
that their sequence identity is less than 26% (Figure 2), but
remained compatible with a common ancestor as shown on
the philogenetic tree (Figure 3). These structural homologies
have been unambiguously conﬁrmed by the determination
of three-dimensional structures of LukF-PV [21], and LukS-
PV [22]. Thr28 in the class S of two component leucotox-
ins aligns with His35 of α-toxin (Figure 2). As an attempt to
verify whether threonine residue of these class S leucotox-
ins has the same role as this His35, amino acid substitutions
were introduced that would predictably disrupt the β-sheet
of these class S proteins, which is highly conserved in the N-
terminus region (Chou and Fassman, and Kite and Doolittle
programs). Ten mutations were performed, eight on LukS-
PV (LukS-PV T28D, LukS-PV T28N, LukS-PV T28N+ΔK43,
LukS-PV T28F, LukS-PV T28L, LukS-PV N30T, LukS-PV
D34C, LukS-PV D34S), one on HlgA (HlgA T28D), and one
on HlgC (HlgC T30D). The puriﬁed proteins showed ap-
parent molecular masses comparable with the staphylococ-
cal native proteins (data not shown). Substitutions of Thr28
by Asp in HlgA and HlgC induced a strong decrease in β-
structure (Table 1) up to 12.5%. In the case of HlgA T28D,
such decrease is compensated by an increase in β-turn struc-
ture,whereasinthecaseofHlgCT30D,thereisanincreasein
the unordered structure. For LukS-PV, there is a decrease in
β-structure for all mutations (less than 3%) except for LukS-
PV T28L (6.5%), but these decreases remain low compared
to HlgA and HlgC mutants (Table 1).
Bindingcapabilitiesofthemutatedproteins
The binding capability of the mutated protein LukS-PV
G10C was ﬁrst tested on polymorphonuclear, monocytes,L. Baba Moussa et al 5
Table 1: Determination of the secondary structure of the leucotoxins by ATR-FTIR. The Lorentzian average corresponds to particular
secondary structure (Byler and Susi). β1 = antiparallel β-sheet, β2 = parallel and antiparallel β-sheet, α = α-helice, t = β-turn and r =
unorganized structure. βtotal = β1 +β2. The errors following the independent testing are ± 5%.
Proteins βttα r ββ total
HlgA 6 . 71 41 51 55 7 6 3
HlgA T28D 9.6 25 4 17 43 53
HlgC 4.3 21 11 5 58 62
HlgC T30D 4 . 72 41 11 44 5 4 9
LukS-PV 10 49 10 8 20 60
LukS-PV T28D 9 4 61 21 02 0 5 6
LukS-PV T28N 8 4 81 21 02 0 5 6
LukS-PV T28N +ΔK 9 4 81 41 11 7 5 7
LuksPV T28F 10 45 12 9 21 56
LuksPV T28L 7 4 61 11 22 2 5 3
LukS-PV N30T 9 5 01 21 11 7 5 9
LukS-PV D34C 6 5 31 31 31 3 5 6
LukS-PV D34S 9 4 71 31 11 8 5 7
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Figure 4: Determination by ﬂow cytometry of LukS-PV G10C
ﬂuorescein-labelled association constant (λex = 488nm, λem =
5nm) with the human monocytes, polynuclears, and lymphocytes
(2 × 105 cell/mL). Polynuclear: KD = 0.13nM; monocyte: KD =
0.04. The LukS-PV Concentration is in nM.
and lymphocytes. Figure 4 shows that the ﬂuorescein-
labelled LukS-PV G10C is able to bind correctly to the target
cells (kiapp = 0.07nM). The binding on lymphocytes was not
detectable. The ﬂuorescent mutated LukS-PV G10C is func-
tional (see below).
In order to determine whether the mutated LukS-PV
proteins are able to bind to the polymorphonuclear, a bind-
ing competition was performed between these mutated pro-
teins and the ﬂuorescein-labelled LukS-PV G10C. Figure 5
showsasimilarbindingofallthemutatedproteinsincompe-
tition with the ﬂuorescent LukS-PV G10C, except for LukS-
PV T28L for which a kiapp could not be determined. The ap-
parent inhibition constants (kiapp) of these proteins are com-
parable to the estimated dissociation constant (KD) of the
native protein (Figure 5). Another kind of binding compe-
tition was performed between each LukS-PV mutated pro-
tein and the class F component HlgB labelled with 5-[4,
6-dichlorotriazin-2-YL]amino-ﬂuorescein(DTAF).Figure 6
shows that only the native LukS-PV allowed the secondary
binding of HlgB-DTAF. When combined with the mutated
protein HlgB-DTAF, LukS-PV mutants are not able to bind
to the cell membrane (Figure 6).
CalciumandethidiumentriesinducedbyLukS-PV
mutatedproteins
Calcium and ethidium entries were measured by ﬂow cy-
tometry. The calcium entry was measured in the presence
of 1nM extracellular calcium and the ethidium entry was
measured in the absence of calcium. Figure 7(a) shows that
the native LukS-PV protein allows a strong entry of Ca2+
and an entry of ethidium. The entry of calcium induced by
the mutated proteins is low. Two mutants, LukSPV T28L
and LukS-PV T28N, displayed an entry of calcium. For the
entry of ethidium, ﬁve mutants: LuksPV T28L, LukS-PV
T28N, LukS-PV T28N+ΔK43, LukS-P T28D, and LukS-PV
D34S, displayed an entry of ethidium (Figures 7(b) and
7(c)), while three mutated proteins: LukS-PV D34T, LukS-
PV D34C, and LukS-PV N30T, were as active as the native
protein.6 Journal of Biomedicine and Biotechnology
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Figure 5:CompetitionbetweentheﬂuorescentLukS-PVG10Cand
the mutated proteins and their binding to the cell, recorded by ﬂow
cytometry.
DISCUSSION
This work shows that the Thr28 of class S component of bi-
component leucotoxins may have a role in the whole struc-
ture because its substitution into a Leucine is responsible
for a dramatic loss of the resulting LukS-PV. However, the
Thr28 residue is a pore directly involved in the secondary
binding and, may be, interaction with class F component.
ThedecreaseintheﬂuorescenceofthenativeLukS-PVG10C
(Figure 5) shows that there is a competition with the mu-
tated protein. All the mutants have an aﬃnity comparable
to wild-type proteins (kiapp∼0.5nM)forLukS-PVreceptor
except T28L which seemed devoid of binding. The substi-
tution of Thr28 by diﬀerent amino acids (Asn(N), Asp(D),
Phe(P), Leu(L), Asn(N) ΔLys(K) 43) induced a decrease in
β-structure up to 12.5% and had an inﬂuence on the sec-
ondary interaction of class F components, thus leading to in-
active toxins. The mutations introduced in the class S pro-
teins on Thr28 never prevent the binding of these proteins
on their membrane ligand, that is, a receptor for LukS-PV
[18], but hindered the secondary binding of class F com-
ponent onto human PMNs. At this stage, Ca2+-activation
and the pore-forming function of the bicomponent leuco-
toxins were both not possible despite their uncoupling re-
mained possible [16, 23]. The sequence identity between α-
toxin and the bipartite leucotoxins is less than 26%, but re-
mains compatible with the existence of a common ancestor
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Figure 6: Determination of the secondary binding of a class F com-
ponent mutated protein onto human PMNs. The determination
of the binding is made by measuring the ﬂuorescence of HlgB-
ﬂuorescein (0.75nM) on bound mutated class S proteins (2nM).
when amino acids, homologies, and structures are consid-
ered.Thr28ofleucotoxins,asHis35ofα-toxin,isprobablyan
amino acid essential for oligomerization and for biological
activity. Other substitutions, N30T and D34S, also aﬀected
the toxin activity suggesting that other residues than Thr28
may be involved in the interaction between the two sub-
units constituting leucotoxins. However, although the leu-
cotoxins are members of the superfamily of β-barrel pore-
forming toxins, they diﬀer from similar toxins like α-toxin
in some aspects. Their binding onto PMN membranes could
be accompanied by the activation of a receptor, while these
cells are not sensitive to α-toxin [18]. On one hand, pores
formed by bipartite leucotoxins are more selective to mono-
valent cations (Na+, K+, ethidium) [24]. Oligomerization
of bicomponent leucotoxins may involve residues at simi-
lar positions as for α-toxin, but one amino acid Tyr101 of
α-toxin aligns with Tyr99 of F components of leucotoxin,
and Tyr99 on HlgB or LukF-PV structures does not look ac-
cessible [21, 25]. In conclusion, the substitutions made on
Thr28 point out its key role in the oligomerization and the
function of the staphylococcal leucotoxins. This observation
conﬁrmed a previous study which showed that when Thr28
of HlgA (or the corresponding Thr30 of HlgC) was substi-
tuted by Asp, the mutants were still able to bind target cells
and compete with the wild type proteins, but the subsequent
binding of HlgB was abolished, with a complete loss of bio-
logical activity [14]. This was observed with human PMNs,
erythrocytes, and PC-Cho small unilamellar vesicles. Thr28
of HlgA aligns with His35 of α-toxin, a crucial residue for
monomer-monomerinteractions[15,26].Asleucotoxinsare
naturally devoid of cysteines into their structure, mutagene-
sis approach might be interesting to stabilize heterodimers
of leucotoxins in order to assess the amino acids involved
in these interactions between S and F proteins of bipar-
tite leucotoxins. The determination of the three-dimensional
structures of LukF-PV [21] and recently for LukS-PV [22]
now enables to challenge some residues in these interac-
tions.L. Baba Moussa et al 7
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Figure 7: Determination by ﬂow cytometry of (a) the opening of calcium channel in the presence of 1mM of calcium by the measurement
of the ﬂuorescence intensity of Fluo-3 (λex = 488nm, λem = 530nm) and (b), (c) the formation of the pores into membranes in absence of
calcium by the measuring of the ﬂuorescence intensity of ethidium (λex = 488nm, λem = 650nm) for LukS-PV and the mutated proteins
(2nM) associated to LukF-PV (0.75nM) on the membrane of human PMNs (2 ×105cells/mL).
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